J Korean Soc Spine Surg. 2001 Sep;8(3):372-377. Korean.
Published online Sep 30, 2001.
https://doi.org/10.4184/jkss.2001.8.3.372
Published online Sep 30, 2001.
https://doi.org/10.4184/jkss.2001.8.3.372
Copyright © 2001 Korean Society of Spine Surgery
Review
Growth Factors and Their Clinical Applications
Seong-Hwan Moon, M.D.,
Hak-Sun Kim, M.D.
and Hwan-Mo Lee, M.D.
Abstract
Growth factor is a polypeptide regulating cell proliferation, maturation, activity, and apoptosis. Despite its small molecular weight, it exerts diverse and potent biologic effects on cellular function. With recent development of molecular biology and vector technology, it is now possible to administer recombinant growth factors in clinical dose and modify somatic cell with growth factor encoding gene. Research fields in spinal surgery can be divided into spinal fusion, disc regeneration and spinal cord regeneration. In this review, we discuss the action mechanism of growth factors and their possible clinical applications especially in the field of spinal fusion and disc regeneration.
Keywords
Growth factor; Spinal fusion; Disc degeneration
Tables
Table 1
Abbreviation used in the text
References
-
Grauer JN, Patel TC, Erulkar JS, Troiano NW, Panjabi MM, Friedlaender GE. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion. Spine 2000;26(2):127–133.
-
-
Helm GA, Alden TD, Beres EJ, Hudson SB, Das S, Engh JA, Pittman DD, Kerns KM, Kallmes DF. Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent. J Neurosurg 2000;92 2 Suppl:191–196.
-
-
Moon SH, Kang JD, Nishida K, Gilbertson LG, Niyibizi C, Smith PN, Knaub MA, Robbins PD, Evans CH. Human cervical intervertebral disc cells are susceptible to adenovirus-mediated gene therapy -Therapeutic gene transfer-; Proceedings of 27th annual meeting, Cervical Spine Research Society; 1999. pp. 150-153.
-
-
Moon SH, Lee HM, Park MS, Kim H, Kang ES, Kim HS, Gilbertson LG, Kang JD. BMP-2 upregulate the mRNA expression of aggrecan, collagen type I, collagen type II in human interverterbal disc cells. Orthopaedic Research Society. 2002(Submitted).
-
-
Moon SH, Nishida K, Gilbertson LG, Hall RA, Robbins PD, Kang JD. Biologic response of human interverterbal disc cells to gene therapy cocktail; Proceedings of Orthopaedic Research Society; 2000.
-
-
Moon SH, Nishida K, Gilbertson LG, Knaub MA, Smith PN, Robbins PD, Evans CH, Kang JD. Proteoglycan synthesis in human intervertebral disc cells cultured in alginate beads: Exogenous TGF-beta1 vs. adenovirus-mediated gene transfer of TGF-beta1 cDNA; Proceedings of Orthopaedic Research Society; 2000.
-
-
Monroe MA, Boden SD, Hair G, Martin GJ Jr, Racine M, Titus L, Hutton WC. Gene expression during autograft lumbar spine fusion and the effect of bone morphogenetic protein 2. Clin Orthop 1998;351:252–265.
-
-
Muschler GF, Hyodo A, Manning T, Kambic H, Easley K. Evaluation of human bone morphogenetic protein 2 in a canine spinal fusion model. Clin Orthop 1994;308:229–240.
-
-
Nishida K, Kang JD, Gilbertson LG, Moon S-H, Suh JK, Vogt MT, Robbins PD, Evans CH. Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: An in vivo study of adenovirus-mediated transfer of the human transforming growth factor β1 encoding gene. Spine 1999;24:2419–2425.
-
-
Schimandle JH, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 1995;20(12):1326–1337.
-
-
Smith P, Shuler FD, Georgescu HI, Ghivizzani SC, Johnstone B, Niyibizi C, Robbins PD, Evans CH. Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1. Arthritis Rheum 2000;43(5):1156–1164.
-
Cited by
MeSH Terms
Tables
Permalink information copied to clipboard